Process for producing ammonium (meth-) acrylate
US-2021348200-A1 · Nov 11, 2021 · US
US12516359B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12516359-B2 |
| Application number | US-202118018561-A |
| Country | US |
| Kind code | B2 |
| Filing date | Apr 19, 2021 |
| Priority date | Oct 9, 2020 |
| Publication date | Jan 6, 2026 |
| Grant date | Jan 6, 2026 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention discloses a nitrilase mutant and application thereof in catalytic synthesis of 2-chloronicotinic acid, and belongs to the technical field of enzyme engineering. The nitrilase mutant has an amino acid sequence shown in SEQ ID NO. 4, that is, 167th tryptophan W of a parent nitrilase is mutated into glycine G. According to the nitrilase mutant provided by the present invention, the hydration activity of the parent nitrilase to 2-chloronicotinonitrile is eliminated, a byproduct of 2-chloronicotinamide is not generated in the catalytic process, the nitrile hydrolysis activity is greatly improved, and 2-chloronicotinonitrile can be specifically subjected to catalytic hydrolysis to synthesize 2-chloronicotinic acid. Therefore, the nitrilase mutant has an important potential in enzymatic industrial synthesis of 2-chloronicotinic acid.
Opening claim text (preview).
What is claimed is: 1 . A nitrilase mutant having the amino acid sequence of SEQ ID NO: 4. 2 . A gene having the nucleotide sequence of SEQ ID NO: 3. 3 . A recombinant plasmid comprising the gene according to claim 2 . 4 . The recombinant plasmid according to claim 3 , wherein the recombinant plasmid is a pET-28b (+) vector that comprises the gene. 5 . A recombinant engineered bacterium comprising the recombinant plasmid according to claim 3 . 6 . The recombinant engineered bacterium according to claim 5 , wherein the recombinant engineered bacterium is a Escherichia coli BL21 cell that comprises the recombinant plasmid. 7 . A method of catalytic hydrolysis of 2-chloronicotinonitrile to synthesize 2-chloronicotinic acid, comprising: culturing a cell transformed with a nucleic acid encoding the protein of SEQ ID NO: 4 to express the protein of SEQ ID NO: 4; sonicating the cell to obtain the protein of SEQ ID NO: 4; reacting the protein of SEQ ID NO: 4 with 2-chloronicotinonitrile in a reaction medium that is a NaH 2 PO 4 —Na 2 HPO 4 buffer solution at a pH between 6 and 8 at a temperature of 25-45° C. to produce 2-chloronicotinic acid, and purifying the 2-chloronicotinic acid. 8 . The method according to claim 7 , wherein the concentration of 2-chloronicotinonitrile in the reaction medium is 50-500 mM. 9 . The method according to claim 8 , wherein the NaH 2 PO 4 —Na 2 HPO 4 buffer solution used as the reaction medium has a pH value of 7, the concentration of 2-chloronicotinonitrile in the reaction medium is 300 mM, and the reaction is performed at 30° C. for 30-40 hours. 10 . A recombinant engineered bacterium comprising the recombinant plasmid according to claim 4 .
Nitrilase (3.5.5.1) · CPC title
Hydroxy-carboxylic acids · CPC title
acting on carbon to nitrogen bonds other than peptide bonds (3.5) · CPC title
containing a six-membered hetero ring · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.